Tele: 561.316.3330
Breaking Medical Device News

Monday, September 20, 2021


HomeHOSPITALSNorthwell Health Awarded for Virtual Care Response During COVID-19 Pandemic

Northwell Health Awarded for Virtual Care Response During COVID-19 Pandemic

July 13, 2020

Northwell Health was awarded the Pandemic Acceleration and Activation Award from national telehealth leader Amwell®. Northwell Health is New York State’s largest health care provider and private employer.

Northwell Health was recognized for its swift virtual response to the coronavirus disease 2019 (COVID-19) pandemic, specifically its ability to enable quality health care to thousands in need through telehealth services.

“I am incredibly proud of the work done by the telehealth teams under extraordinary circumstances to make sure our patients could receive the care they needed from Northwell physicians and other members of our clinical teams too numerous to name,” said Dr. Martin Doerfler, MD, senior vice president of clinical strategy and development at Northwell.

Northwell’s telehealth program grew exponentially during the pandemic, integrating more than 65 departments into the scheduled visit workflow and increasing the number of providers on the Amwell system from a few hundred daily to over 5,000 virtual visits every day.

The ability to rapidly scale the virtual care program allowed Northwell to maintain care to patients, especially those in the most vulnerable populations. The program will remain a strong part of the way Northwell delivers care to patients in the future – not just during times of crisis, but regularly to those who would have difficulty accessing health care otherwise.

Northwell treated more COVID-19 patients than any other health system in the nation between March and June, including about 17,000 hospitalized patients. Accounting for those seen in the health system’s emergency departments, urgent care centers, physician practices and virtually, Northwell provided medical care to more than 55,000 COVID-19 patients overall.

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy